Cryo-Cell International, Inc. revenue by segment CCEL

Annual Quarterly

Cryo-Cell International, Inc. splits its revenue 2 ways in its filings. By operating segments, the largest line in fiscal 2025, which ended Nov 30, 2025 was Umbilical Cord Blood And Cord Tissue Stem Cell Service at $31.4 million, 99% of the total. By sales mix, the largest line in fiscal 2025, which ended Nov 30, 2025 was Processing And Storage Fees at $31.4 million, 99% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2026 Aug 31, 2026	FY 2025 Nov 30, 2025	FY 2024 Nov 30, 2024	FY 2023 Nov 30, 2023	FY 2022 Nov 30, 2022	FY 2021 Nov 30, 2021	FY 2020 Nov 30, 2020	FY 2019 Nov 30, 2019	FY 2018 Nov 30, 2018	FY 2017 Nov 30, 2017	FY 2016 Nov 30, 2016
Revenue	31	32	32	31	30	29	31	32	29	25	23
Operating segments
Umbilical Cord Blood And Cord Tissue Stem Cell Service	31 -1.8% share 99.1%	31 -0.5% share 99.4%	32 +2.5% share 98.6%	31 +3.4% share 98.3%	30 +4.8% share 98.1%	28 -5.9% share 98.3%	30 share 96.9%	—	—	—	—
Public Cord Blood Banking	0 -36.7% share 0.6%	0 -64.7% share 0.4%	0 -23.8% share 1.1%	0 +4.2% share 1.5%	0 +22.7% share 1.5%	0 -48.2% share 1.3%	1 share 2.3%	—	—	—	—
Prepacytecb	0 +71.4% share 0.4%	0 -20.3% share 0.2%	0 +2.1% share 0.2%	0 -36.1% share 0.2%	0 -6.6% share 0.3%	0 -54.4% share 0.4%	0 share 0.8%	—	—	—	—
Sales mix
Processing And Storage Fees	31 -1.8% share 99.1%	31 -0.5% share 99.4%	32 +2.5% share 98.6%	31 +3.4% share 98.3%	30 +4.8% share 98.1%	28 -3.9% share 98.3%	30 share 94.9%	—	—	—	—
Public Banking	0 -36.7% share 0.6%	0 -64.7% share 0.4%	0 -23.8% share 1.1%	0 +4.2% share 1.5%	0 +22.7% share 1.5%	0 -48.2% share 1.3%	1 share 2.3%	—	—	—	—
Product	0 +71.4% share 0.4%	0 -20.3% share 0.2%	0 +2.1% share 0.2%	0 -36.1% share 0.2%	0 -6.6% share 0.3%	0 -54.4% share 0.4%	0 share 0.8%	—	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as: CCEL (NYSE)
Fiscal year ends: November 30
Incorporated in: DE
Headquarters: Oldsmar, FL
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 862692
Former names: CRYO CELL INTERNATIONAL INC (until Oct 28, 2026)

Other Services-Misc Health & Allied Services, NEC companies

All 15 Services-Misc Health & Allied Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.